Valeria Feinshtein
Beersheba, D 84105, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Investigating the anticancer activity of eravacycline in pancreatic cancer via target-based deep learning and experimental validation.
Journal: Briefings in bioinformatics
Published: July 06, 2025
Targeted Polymer-Peptide Conjugates for E-Selectin Blockade in Renal Injury.
Journal: Pharmaceutics
Published: December 05, 2024
Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model.
Journal: Briefings in bioinformatics
Published: December 06, 2023
Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery.
Journal: Molecules (Basel, Switzerland)
Published: August 25, 2023
Selected cannabis cultivars modulate glial activation: in vitro and in vivo studies.
Journal: Journal of cannabis research
Published: June 06, 2023
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo.
Journal: Biomolecules
Published: December 25, 2022
Non-Pigmented Ciliary Epithelium-Derived Extracellular Vesicles Loaded with SMAD7 siRNA Attenuate Wnt Signaling in Trabecular Meshwork Cells In Vitro.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 12, 2021
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency.
Journal: International journal of pharmaceutics
Published: July 19, 2020
Attenuation of neutrophil-mediated liver injury in mice by drug-free E-selectin binding polymer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 25, 2019
The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts.
Journal: Drug design, development and therapy
Published: December 26, 2018
CD44-Targeted Polymer-Paclitaxel Conjugates to Control the Spread and Growth of Metastatic Tumors.
Journal: Molecular pharmaceutics
Published: June 30, 2018
Last Updated: 09/26/2026